Metraipolis › archive › dc_3f52e68c8382
Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects — Europe PMC PMID:42147788
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42147788
- DOI
- 10.1093/ckj/sfag058
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T23:59:04.506Z
- SHA-256 of the archived text
a70b535c82162bb2a7b2240e4baf9c2e07ce696e9ef19dd49b85f007b2eaa22f- Stable URL of this page
https://metraipolis.com/documento/dc_3f52e68c8382
How to cite
Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects — Europe PMC PMID:42147788 — Europe PMC (en), https://europepmc.org/article/MED/42147788 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f52e68c8382 (Metraipolis archive dc_3f52e68c8382, sha256 a70b535c82162bb2a7b2240e4baf9c2e07ce696e9ef19dd49b85f007b2eaa22f)
BibTeX
@misc{dc3f52e68c8382,
title = {Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects — Europe PMC PMID:42147788},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42147788},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f52e68c8382; sha256 a70b535c82162bb2a7b2240e4baf9c2e07ce696e9ef19dd49b85f007b2eaa22f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42147788. Agents can read the archived copy with the MCP tool read_document.